FDA lifts clinical hold on Ocugen's Covid-19 vaccine study; stock skyrockets By: Philadelphia Business Journal via Business Journals February 18, 2022 at 18:09 PM EST The FDA in November temporarily put the brakes on Ocugen's plan to test Covaxin in the United States. Read More >>
